B.Tech in Bio – Technology Program
The biotechnology sector, mainly due to its multidisciplinary approach, holds the potential to provide an array of solutions for challenges in various sectors such as health, agriculture, environment, energy and industrial processes. The global biotechnology market size was valued at USD 752.88 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.83% from 2021 to 2028.
By 2025, contribution of the Indian biotechnology industry in the global biotechnology market is expected to increase to ~19%. India is among the top 12 biotechnology destinations in the world and the 3rd largest in Asia-Pacific. The Indian bioeconomy grew from US$ 62.5 billion in 2019 to US$ 70.2 billion in 2020 at a growth rate of 12.3% and is likely to register a CAGR of 16.4% to reach US$ 150 billion by 2025.
The Indian biotech industry consists of 4,240 biotech start-ups and is expected to grow to 10,000 by 2024. As of February 2022, India has almost 5000 biotech companies. India has 665 FDA-approved plants outside of the US, which is the highest in the world. India also has 44% share of the global abbreviated new drug applications (ANDA) and >1400 manufacturing plants which comply with WHO requirements. As of 2020, biopharmaceuticals contributed 62% to the Indian bioeconomy, followed by bio-agriculture (16%), bio-services (15%) and bio-industrial (7%).
4-Yr B.Tech. Biotechnology program with possibility to continue into integrated 5-Yr M.Tech. Biotechnology.
Delivered through specific courses and intensive industry project.
Core Technical Competencies to be Developed Through the Program
Omics technologies, novel applications of gene/ genome sequencing in diverse biotech domains.
Gene cloning, genome editing, CRISPR, genetic disorders, gene therapy, gene silencing, transgenic plants and animals.
Genomics of genetic disorders, discovery of novel drug targets, cell therapy, drug delivery technologies.
Lab-on-a chip i.e. militarized labs for rapid testing in biopharma drug screening and disease modelling, facilitating point-of-care diagnosis, paper-based microfluidics for diagnostics.
Cell cultures, fermentation, recombinant production of medical products & therapies, biomaterials, food & beverages, specialty chemicals, ML in automation, precision biomanufacturing.
Manipulating organisms at gene networks, cellular agriculture, microbiome-based solutions, cell factories to provide valuable biochemicals in pharma, materials, and food, mammalian synthetic biology.
Tissue grafts to treat burns, organ transplanting, regenerative medicine, cultured meat, etc.
AI & Big Biological Data
Drug discovery, biomarkers, literature mining, images classification for rapid detection, medical scans, decision support in digital agritech.
GMP & Regulatory Affairs
Product quality, safety, regulatory procedures, etc.
Bioprinters, bio-inks, bio-base materials, medical applications, vascular grafts from patient’s own cells for personalized medicine